are characterized by the following factors: young age of patients, mixed-lineage immunophenotype with coexpression of T-cell and myeloid antigens, extramedullary involvement, T-cell receptor gd (TCRgd) lineage, and poor clinical outcome [6, 7] .
Recently, several genes of the homeobox A (HOXA) cluster, including HOXA5, HOXA9, and HOXA10, were shown to be upregulated in CALM-AF10-positive leukemic cells, with expression profiles similar to those of mixed-lineage leukemia (MLL)-AF10 fusion gene-positive leukemias [8] .
Overexpression of HOXA5 through the methylation of lysine 79 of histone H3 (H3K79), mediated by human DOT1-like, histone H3 methyltransferase (hDOT1L) has been suggested as the key mechanism by which the CALM-AF10 fusion gene causes leukemogenesis [9] . Here, we report 2 cases of CALM-AF10-positive leukemias with a HOXA gene cluster/hDOT1L expression pattern. To our knowledge, only a single case of CALM-AF10-positive AML has previously been reported in Korea [10] . This is the first report of CALM-AF10-positive ALL in Korea.
CASE REPORTS

Case 1
An 18-yr-old woman was referred for further evaluation and treatment of a neck mass and cytopenia. A physical examination revealed a non-tender, fixed 5-cm mass on the left side of the neck. A complete blood cell count and peripheral blood smear showed white blood cell (WBC) and platelet counts of 10.4×10 9 /L and 193×10 9 /L, respectively, with 37% leukemic blasts; the hemoglobin level was 9.2 g/dL. The bone marrow was hypercellular, with diffuse infiltration of leukemic blasts (67%) (Fig. 1A) . Immunophenotyping of bone marrow cells showed positive expression of cytCD3 (89%), CD7 (88%), CD13 (87%), CD33 (24%), CD34 (89%), and Tdt (89%); the cells were negative for myeloper- (Table 1) were designed on the basis of the known cDNA sequences.
The CALM-AF10 fusion transcript was detected by RT-PCR in samples obtained from both the patients (Fig. 2) .
In each case, sequencing analyses revealed breakpoints at nucleotides 2091 and 424 in CALM and AF10, respectively, which corresponded to the breakpoints in the U937 cell line.
Both patient samples showed expression of the HOXA gene cluster and hDOT1L. In the first patient (case 1), the RT-PCR expression pattern of HOXA and hDOT1L genes was associated with the clinical outcome (Fig. 3) .
DISCUSSION
The CALM-AF10 rearrangement was first observed in a patient with diffuse histiocytic lymphoma; the U937 cell line was established from this patient and was found to display many monocytic characteristics [11] . The CALM-AF10 rearrangement has been observed as a rare but recurring phenomenon in acute leukemias of several lineages, including myeloid, T-cell lymphoblastic, and megakaryocytic leukemias, as well as malignant lymphoma, and is considered to be indicative of a poor clinical outcome [2] [3] [4] .
The incidence of CALM-AF10 fusion transcripts in acute leukemia has not been well documented, although one study showed that CALM-AF10 transcripts were present in 9%
of 131 T-cell ALL patients and was the most common fusion HOXA5_F 5′ - GTCCACGCACTCTCCTCAG-3′  HOXA5_R  5′ -CTTCATTCTCCGGTTTTGGA-3′  HOXA7_F  5′ -TCAACAGCCCCCTTTATCAG-3′  HOXA7_R  5′ -GCTCTTTCTTCCACTTCATGC-3′  HOXA9_F  5′ -TAAACCTGAACCGCTGTCG-3′  HOXA9_R  5′ -CATTTTCATCCTGCGGTTCT-3′  HOXA10_F  5′ -GCTACTTCCGCCTTTCTCAG-3′  HOXA10_R 5′ -GACGCTGCGGCTAATCTCTA-3′ hDOT1L_F 5′ -CAAGTTCTCGCTGCCTCACT-3′ hDOT1L_R 5′ -GTCCTGAGGGCTCAGCTTC-3′ Name Sequence Table 1 . Primers used in PCR amplification gene in patients with TCRgd-lineage T-cell ALL [7] .
Recently, CALM-AF10-positive leukemias were found to be characterized by the overexpression of HOXA5, HOX-A9, HOXA10, and the BMI1 polycomb ring finger oncogene (BMI1) [8] . Okada et al. [9] reported that leukemic transformation by CALM-AF10 was mediated by the recruitment of the histone methyltransferase hDOT1L, which methylates H3K79. hDOT1L was also found to interact with an octapeptide motif and a leucine-zipper (OM-LZ) region of AF10; this interaction inhibits the nuclear export of CALM-AF10. Both hDOT1L-mediated methylation of H3K79, which results in the overexpression of several HOXA genes, and nuclear sequestration of CALM-AF10 contribute to leukemic transformation by CALM-AF10 [9, 12] . Among the upregulated HOXA genes, HOXA5 has been shown in a HOXA5-knockout mouse model to be critical for leukemic transformation by the CALM-AF10 fusion gene [9] . In the present report, the genes HOXA5, HOXA7, HOXA9, HOXA10, and hDOT1L were expressed in both the patients. Achievement of hematologic remission in case 1 was associated with the suppression of HOXA and hDOT1L gene expression; these genes were re-expressed upon relapse. HOXA gene expression is associated with early hematopoiesis and is generally downregulated during differentiation [13] . In 
